Quarterly report pursuant to Section 13 or 15(d)

Net Loss Per Share (Details) - Schedule of diluted net loss per share

v3.21.1
Net Loss Per Share (Details) - Schedule of diluted net loss per share - shares
 3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Total common stock equivalents 815,311 1,500,511 815,311 1,500,511
Stock options [Member]        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Total common stock equivalents 173,041 188,595 173,041 188,595
Warrants [Member]        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Total common stock equivalents 642,270 1,311,916 642,270 1,311,916